Vizsgálatok, publikációk és pályázatok 2024. nov. óta.
Publikáció
Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.
Blood advances, 2026. szept.
Publikáció
Primary Plasma Cell Leukemia.
American journal of hematology, 2026. aug.
Publikáció
Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.
European journal of haematology, 2026. aug.
Publikáció
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.
American journal of hematology, 2026. aug.
Publikáció
Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management.
American journal of hematology, 2026. aug.
Publikáció
Monoclonal Gammopathy of Thrombotic Significance.
American journal of hematology, 2026. aug.
Publikáció
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.
British journal of haematology, 2026. aug.
Publikáció
De-escalation trials in multiple myeloma: past, present and future.
Nature reviews. Clinical oncology, 2026. júl.
Publikáció
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026. júl.
Publikáció
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.
Leukemia, 2026. júl.
Publikáció
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma.
Blood cancer journal, 2026. júl.
Publikáció
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.
American journal of hematology, 2026. jún.
Publikáció
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.
Blood cancer journal, 2026. jún.
Publikáció
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.
American journal of hematology, 2026. jún.
Publikáció
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype.
British journal of haematology, 2026. máj.
Publikáció
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myeloma.
Leukemia, 2026. ápr.
Publikáció
Efficacy of CD38-Targeted Therapy in Severe, Multi-Agent Refractory Immune Thrombocytopenia: A Case Series.
European journal of haematology, 2026. ápr.
Publikáció
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.
British journal of haematology, 2026. márc.
Publikáció
Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.
British journal of haematology, 2026. márc.
Publikáció
Immunoglobulin Light Chain Amyloidosis.
Mayo Clinic proceedings, 2026. febr.
Publikáció
Diagnosis, risk stratification and management of smouldering multiple myeloma.
Nature reviews. Clinical oncology, 2026. jan.
Publikáció
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma.
Blood cancer journal, 2026. jan.
Publikáció
Measurable residual disease assessment in multiple myeloma.
Leukemia, 2025. dec.
Publikáció
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.
Blood cancer journal, 2025. dec.
Publikáció
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance.
Blood cancer journal, 2025. nov.
Publikáció
Defining IgM Multiple Myeloma.
American journal of hematology, 2025. okt.
Publikáció
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis.
Leukemia, 2025. szept.
Publikáció
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.
Blood cancer journal, 2025. aug.
Publikáció
Risk of lymphoid malignancy associated with cancer predisposition genes.
Blood cancer journal, 2025. ápr.
Publikáció
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis.
Blood cancer journal, 2025. márc.